Key Events This Week
27 Jul: Stock opens strong at Rs.413.95 (+1.81%) amid mixed market signals
28 Jul: Technical momentum shifts to mildly bearish; stock dips to Rs.409.25 (-1.14%)
30 Jul: Sharp gap down and new 52-week low at Rs.376.9; Q1 FY27 results reveal steep profit decline
31 Jul: Downgrade to strong sell and average quality; stock closes at Rs.385.65 (-3.31%)
27 July 2026: Initial Gains Amid Mixed Technical Signals
Syngene International Ltd started the week on a positive note, closing at Rs.413.95, up 1.81% from the previous close. This gain outpaced the Sensex’s 1.05% rise to 36,207.16, suggesting some short-term buying interest. However, technical analysis indicated a nuanced momentum shift. While the weekly MACD showed mild bullishness, longer-term monthly indicators remained bearish, signalling caution. The stock traded within a range of Rs.404.80 to Rs.415.25, still far below its 52-week high of Rs.728.40, reflecting persistent volatility and underlying weakness.
28 July 2026: Technical Momentum Shifts to Mildly Bearish
The following day, the stock slipped 1.14% to Rs.409.25, underperforming the Sensex which declined marginally by 0.14%. This decline coincided with a technical momentum shift from outright bearish to mildly bearish, as indicated by mixed signals from MACD and KST oscillators. The Relative Strength Index (RSI) remained neutral, suggesting consolidation rather than a decisive trend reversal. Despite the short-term pullback, volume increased to 21,882 shares, indicating active trading amid uncertainty.
This week's revealed pick, a Large Cap from Public Banks with TARGET PRICE, is already showing movement! Get the complete analysis before it's too late.
- - Target price included
- - Early movement detected
- - Complete analysis ready
30 July 2026: Sharp Gap Down and New 52-Week Low Amid Profit Decline
On 30 July, Syngene International Ltd opened with a significant gap down of 7.4%, closing the day at Rs.398.85, down 3.58%. The stock hit a new 52-week low of Rs.376.9 intraday, marking an 8.88% drop from the previous close. This sharp decline was driven by the release of Q1 FY27 results, which revealed a 28.99% fall in net sales and a staggering 95.0% drop in profit after tax to Rs.4.50 crores. Earnings per share turned negative at Rs.-0.22, and return on capital employed (ROCE) fell to 10.12%, the lowest in recent quarters. The operating profit to interest coverage ratio also declined to 9.46 times, signalling tighter earnings relative to financial obligations.
The stock’s underperformance was stark compared to the Sensex’s modest 0.05% gain and the healthcare sector’s strength, with sector indices reaching new highs. This divergence highlighted company-specific challenges rather than broader market weakness. The stock traded below all key moving averages, reinforcing the bearish technical stance amid heightened volatility and a trading volume surge to over 1.5 million shares.
31 July 2026: Downgrade to Strong Sell and Average Quality Amid Continued Weakness
On the final trading day of the week, Syngene International Ltd’s stock closed at Rs.385.65, down 3.31%. The company’s quality rating was downgraded from good to average, and its Mojo Grade was lowered from sell to strong sell, with a Mojo Score of 19.0. This downgrade reflected deteriorating fundamentals, including sluggish sales growth averaging 8.84% annually over five years, negative operating profit growth of -4.05%, and declining returns on equity and capital employed.
Valuation concerns intensified as the stock traded at a price-to-book ratio of 3.3 despite falling profits. Technical indicators confirmed a shift to outright bearish momentum, with daily moving averages firmly negative and Bollinger Bands signalling continued downside risk. The Relative Strength Index remained neutral, but the overall technical picture suggested sustained selling pressure. Institutional investors hold a significant 39.83% stake, yet the downgrade and recent price declines may prompt reassessment of positions.
Is Syngene International Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Daily Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-07-27 | Rs.413.95 | +1.81% | 36,207.16 | +1.05% |
| 2026-07-28 | Rs.409.25 | -1.14% | 36,155.32 | -0.14% |
| 2026-07-29 | Rs.413.65 | +1.08% | 36,524.95 | +1.02% |
| 2026-07-30 | Rs.398.85 | -3.58% | 36,541.96 | +0.05% |
| 2026-07-31 | Rs.385.65 | -3.31% | 36,684.83 | +0.39% |
Key Takeaways
1. Financial Deterioration: The sharp 95.0% decline in Q1 PAT and 28.99% fall in net sales highlight deepening operational challenges, contributing to the stock’s steep decline and rating downgrade.
2. Technical Weakness: The stock’s breach of all major moving averages, coupled with bearish MACD and Bollinger Bands on monthly charts, signals sustained downward momentum.
3. Relative Underperformance: Syngene’s 5.15% weekly loss contrasts sharply with the Sensex’s 2.39% gain, underscoring company-specific issues rather than market-wide weakness.
4. Quality and Valuation Concerns: Downgrade to average quality and a strong sell rating reflect deteriorating fundamentals and expensive valuation metrics, raising caution for investors.
Overall, Syngene International Ltd’s week was marked by significant setbacks both fundamentally and technically. The stock’s inability to participate in broader market gains and sector strength, combined with worsening financial results and a downgraded rating, suggest a challenging near-term outlook.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
